Evolva announced the signing of a distribution agreement with Tovani Benzaquen Ingredients to jointly develop the Brazilian business for Veri-teTM Resveratrol. The agreement provides Evolva with access to an attractive segment of the Brazilian market for dietary supplements. Revenues are expected to exceed a minimum of CHF 1.5 million over the next 2.5 years from this partnership.

Evolva's Veri-teTM Resveratrol is approved for sale in dietary supplements in Brazil by the Brazilian regulator ANVISA (Agência Nacional de Vigilância Sanitária) and the signing of this distribution agreement with Tovani now allows Evolva to capitalize on the market potential.